In this post you will learn about the ongoing firefighter foam cancer lawsuit, as chemicals in aqueous film-forming foam (AFFF) may lead to various cancers. If you’ve been diagnosed with kidney, pancreatic, prostate, or testicular cancer after exposure to AFFF as a firefighter or otherwise, you may be eligible for compensation through legal action.

With over 3,300 plaintiffs involved as of February 2024, all federal lawsuits have been consolidated to the United States Federal Court in the District of South Carolina under the Judicial Panel on Multi-District Litigation (JPMDL).

March 1, 2024

MDL Continues Expansion Amid Legal Developments

Despite a previous settlement addressing water contamination concerns, the AFFF firefighting foam MDL shows no signs of slowing down, with 176 new cases added over the past month. This sustained growth underscores the persistent challenges faced by individuals impacted by AFFF exposure and highlights the imperative for continued legal advocacy on their behalf. As the MDL unfolds, stakeholders remain committed to advancing the interests of affected parties and securing meaningful redress for their grievances.

February 9, 2024

Landmark Settlement Paves Way for AFFF Litigation

A recent landmark settlement addressing water contamination issues has laid the groundwork for a renewed focus on AFFF firefighting foam lawsuits. With a federal judge granting final approval to the $1.18 billion agreement involving key industry players, including DuPont, Chemours, and Corteva, the stage is set for a recalibration of legal strategies in pursuit of justice for affected individuals. As the AFFF litigation landscape evolves, stakeholders remain poised to navigate the complexities of mass tort litigation with diligence and determination.

February 2, 2024

Continuing Influx of AFFF Lawsuits

The AFFF firefighting foam class action MDL has witnessed a steady influx of new cases, with 279 additions in January alone, bringing the total tally to 6,994 pending cases. Against the backdrop of a global settlement deal addressing water contamination claims, the surge in litigation underscores the enduring impact of AFFF exposure on individuals grappling with serious health consequences. As legal proceedings unfold, stakeholders navigate the complex terrain of mass tort litigation with a steadfast commitment to securing equitable outcomes for affected parties.

January 26, 2024

Litigation Focus Shifts Amidst MDL Growth

Efforts to streamline the AFFF litigation landscape have intensified, with discussions underway to separate personal injury claims from water contamination cases within the MDL. This strategic move aims to foster greater precision and efficacy in addressing the unique legal challenges posed by AFFF firefighting foam lawsuits. As the litigation landscape evolves, stakeholders remain vigilant in their pursuit of justice and accountability.

January 15, 2024

Further Increase in MDL Caseload

Despite the holiday season, the AFFF firefighting foam class action MDL has recorded a notable uptick, with 88 new cases added to the roster. Remarkably, AFFF stands out as the only mass tort MDL experiencing such a substantial surge during this period. The surge in litigation underscores the pressing need for comprehensive legal recourse for victims affected by the alleged harmful effects of AFFF exposure.

January 10, 2024

Emergence of New AFFF Lawsuit

A recent filing in Alabama has brought forth another AFFF lawsuit, alleging exposure to per- and polyfluoroalkyl substances (PFAS), including PFOS and PFOA, leading to the development of testicular cancer. The plaintiff’s claim, lodged initially in state court, has since been transferred to federal court, thereby adding to the ongoing MDL. This latest case exemplifies the persistent legal battles faced by individuals grappling with the aftermath of AFFF exposure.

January 1, 2024

MDL Surpasses 6,600 Cases

In a significant development, the Multi-District Litigation (MDL) concerning Aqueous Film-Forming Foam (AFFF) or “firefighting foam” has expanded further, with over 6,600 total cases now pending. Since the resolution of water contamination cases earlier this year through a global settlement, the influx of new cases, primarily related to personal injury claims, has continued unabated. The surge in litigation underscores the growing concerns surrounding the potential health risks associated with exposure to PFAS-containing firefighting foam.

Cancers Associated with AFFF Firefighting Foam

Exposure to Aqueous Film-Forming Foam (AFFF), commonly used in firefighting, has been linked to several types of cancer, including pancreatic, kidney, breast, liver, leukemia, bladder, ovarian, non-Hodgkin’s lymphoma, testicular, and prostate cancer.

Defendants in AFFF Litigation

Numerous defendants are facing litigation over their involvement in the manufacturing and sale of fluorochemicals and related products. These include industry giants such as DuPont, 3M, BASF Corporation, Chemours, Corteva, Arkema, AGC Chemicals Americas, Dynax Corporation, Kidde-Fenwal Inc., and Clariant Corporation.

Eligibility for Filing a Firefighting Foam Lawsuit

To qualify as a plaintiff in an AFFF lawsuit, individuals must meet two primary criteria:

1. Exposure to PFAS: Prospective plaintiffs must demonstrate regular and prolonged exposure to firefighting foam. This includes individuals who used AFFF as part of their occupation, such as firefighters, airport maintenance crew, and factory workers.
2. Cancer Diagnosis: Exposure to PFAS alone is insufficient to establish a valid claim. Plaintiffs must also show a diagnosis of certain types of cancer following prolonged AFFF exposure. The most strongly linked cancers include kidney and testicular cancer, though pancreatic and prostate cancer have also been associated with AFFF use.

Our team is currently accepting new cases concerning firefighting foam from clients who meet the following criteria:

• Occupational exposure to AFFF (firefighting foam) for a minimum of one year; and
• Diagnosis of one of the following types of cancer: pancreatic, testicular, prostate, or kidney.

If you meet these criteria, please contact us immediately to initiate the filing of your AFFF claim as soon as possible.

You may be eligible to participate in the AFFF lawsuit settlement if you have developed cancer due to exposure to AFFF foam.

Our team is prepared to assist with your potential claim. Call our experts today at 323-763-8247 for further assistance!